Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Sarcoma 10 Lymphoma, Large B-Cell, Diffuse 7 Lymphoma 7 Ovarian Neoplasms 4 Lymphoma, Non-Hodgkin 4 Lung Neoplasms 4 Leukemia 4 Carcinoma, Non-Small-Cell Lung 4 Testicular Neoplasms 3 Small Cell Lung Carcinoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neuroblastoma 3 Hodgkin Disease 3 Central Nervous System Neoplasms 3 Testicular Germ Cell Tumor 2 Relapsed Pediatric Solid Tumor 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Lymphoma, T-Cell, Peripheral 2 Fallopian Tube Neoplasms 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Unresectable Sinonasal Tumors 1 Teratoma 1 Subcutaneous panniculitis-like T-cell lymphoma 1 Spinal Cord Neoplasms 1 Sinonasal Tumors 1 Seminoma 1

Interventions

Ifosfamide 1 Ice 1 Etoposide 1 Craniospinal Irradiation 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Intracranial Germ Cell Tumors × Ifosfamide × Clear all

NCT01424839 2015-06-04

SIOPCNSGCTII

University Hospital Muenster

Phase 4 Unknown

Intracranial Germ Cell Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡